Kallistem is a biotech company specialized in spermatogenesis. The company was founded in 2012 with the objective to anticipate and treat male infertility. It promotes a technology and expertise developed by Philippe Durand and Marie-Helene Perrard, two internationally renowned scientists in the field of the reproductive biology and more specially in in vitro spermatogenesis. Kallistem has developed, in collaboration with its partners, original and innovating technologies of germinal cell culture for male fertility preservation and the treatment of male infertility.
View Top Employees from KallistemWebsite | http://www.kallistem.com |
Revenue | $1 million |
Employees | 3 (3 on RocketReach) |
Founded | 2012 |
Address | 1 Ave Bourgelat, Marcy-l'Etoile, Auvergne-Rhone-Alpes 69280, FR |
Phone | +33 7 62 41 67 35 |
Technologies |
JavaScript,
Twitter,
Google Analytics
+5 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biotechnology, Male Fertility, Business Services, Science and Engineering, Cellular Therapy, Chemical, Biology Of Reproduction, Fertility, Testicular Toxicology, Health Care, Medical |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 541713 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 54171 Companies |
Looking for a particular Kallistem employee's phone or email?
The Kallistem annual revenue was $1 million in 2024.
3 people are employed at Kallistem.
Kallistem is based in Marcy-l'Etoile, Auvergne-Rhone-Alpes.
The NAICS codes for Kallistem are [54, 541713, 5417, 541, 54171].
The SIC codes for Kallistem are [87, 873].